ReNeuron Group Plc Company Profile (LON:RENE)

Analyst Ratings

Consensus Ratings for ReNeuron Group Plc (LON:RENE) (?)
Ratings Breakdown: 1 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: GBX 10

Analysts' Ratings History for ReNeuron Group Plc (LON:RENE)
Show:
DateFirmActionRatingPrice TargetActions
1/4/2016N+1 SingerReiterated RatingBuyGBX 10View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/29/2014 forward)

Earnings

Earnings History for ReNeuron Group Plc (LON:RENE)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for ReNeuron Group Plc (LON:RENE)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for ReNeuron Group Plc (LON:RENE)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for ReNeuron Group Plc (LON:RENE)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
2/17/2016Hunt,MichaelInsiderSell509,554GBX 3£15,286.62Tweet This Trade  Share This Trade on StockTwits
2/12/2016Hunt,MichaelInsiderSell594,637GBX 3£17,839.11Tweet This Trade  Share This Trade on StockTwits
2/11/2016Hunt,MichaelInsiderSell1,208,333GBX 3£36,249.99Tweet This Trade  Share This Trade on StockTwits
2/5/2016Hunt,MichaelInsiderSell1,035,533GBX 3£31,065.99Tweet This Trade  Share This Trade on StockTwits
2/2/2016Edward Berriman,JohnInsiderBuy318,476GBX 3£9,554.28Tweet This Trade  Share This Trade on StockTwits
1/29/2015Olav HellebøInsiderBuy322,778GBX 3.10£10,006.12Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for ReNeuron Group Plc (LON:RENE)
DateHeadline
07/23/16 09:58 AMReNeuron unveils positive pre-clinical data from eye trial
07/22/16 05:55 PMReNeuron publishes positive data from its FDA retinitis pigmentosa application - Proactive Investors UK
07/22/16 09:02 AMReNeuron : Retinal stem cell data paves way for clinical research
07/22/16 09:02 AMReNeuron publishes positive data from its FDA retinitis pigmentosa application
07/20/16 08:54 AMA Reversal for ReNeuron Group Plc Is Not Near. The Stock Rises Again - Consumer Eagle
07/18/16 11:35 AMShrinking Pools of Money, Talent May Bind Biotechs After Brexit - Bloomberg
07/18/16 11:35 AMReNeuron Group (LON:RENE) New Price Targets - FTSE News
07/14/16 09:43 AMNew Analyst Ratings For ReNeuron Group (LON:RENE) - Fiscal Standard
07/11/16 10:46 AMOutstanding Analyst Ratings For ReNeuron Group (LON:RENE) - FTSE News
07/08/16 06:03 PMMajor milestones ahead, says ReNeuron CFO Michael Hunt - Proactive Investors UK
07/08/16 08:58 AMReNeuron : Annual Loss Widens As Product Trials Ramp Up
07/08/16 08:58 AMMajor milestones ahead, says ReNeuron CFO Michael Hunt
07/07/16 06:09 PMReNeuron Group (LON:RENE) Analyst Target Prices - FTSE News
07/07/16 06:09 PMReNeuron Group Pipeline Review, Market Share, Stragegy, Size and Forecast 2016 to 2020 - Medgadget (blog)
07/07/16 06:09 PMReNeuron hails a year of significant progress - Proactive Investors UK
07/07/16 08:55 AMUK Stocks-Factors to watch on July 7
07/07/16 08:55 AMReNeuron Annual Loss Widens As Product Trials Ramp Up
07/07/16 08:55 AMReNeuron hails a year of significant progress
07/07/16 06:07 AMFull Year 2016 ReNeuron Group PLC Earnings Release - Before Market Open -
07/07/16 02:21 AMPreliminary Results for the Year Ended 31 March 2016 - [at noodls] - Consolidated income statement 7 July 2016 AIM: RENE ReNeuron Group plc ("ReNeuron" or "the Company") ReNeuron Group plc (AIM: RENE), a UK-based global leader in the development of cell-based ...
06/29/16 08:52 AMReNeuron Group (LON:RENE) Broker Updates - Fiscal Standard
06/15/16 10:38 AMReNeuron completes recruitment for phase II stroke trial - Proactive Investors UK
06/14/16 10:53 AMReNeuron : Notification of Preliminary Results
06/14/16 04:29 AMPatient recruitment completed in Phase II stroke clinical trial - [at noodls] - Consolidated income statement 13 June 2016 AIM: RENE ReNeuron Group plc ReNeuron Group plc (the "Company") (AIM: RENE), a UK-based global leader in the development of cell-based therapeutics, ...
06/13/16 05:40 PMReNeuron : Patient recruitment completed in stroke trial
06/13/16 05:40 PMReNeuron completes recruitment for phase II stroke trial
06/13/16 09:03 AMFitbug catches cold as FTSE 100 Index drops - Proactive Investors UK
06/13/16 09:03 AMReNeuron completes recruitment for phase II stroke trial - Proactive Investors USA & Canada
06/13/16 02:19 AMPatient recruitment completed in stroke trial - [at noodls] - ReNeuron Group plc Patient recruitment completed in Phase II stroke clinical trial ReNeuron Group plc (the 'Company') (AIM: RENE), a UK-based global leader in the development of cell-based therapeutics, ...
06/09/16 09:04 AMReNeuron to tackle brain cancer with exosome candidate - Proactive Investors UK
06/09/16 02:29 AMPursues brain cancer with exosome platform - [at noodls] - AIM: RENE 9June 2016 ReNeuron Group plc ReNeuron to pursue brain cancer as first clinical target for exosome nanomedicine platform ReNeuron Group plc (the 'Company') (AIM: RENE), a UK-based global leader ...
06/09/16 02:29 AMReNeuron to pursue brain cancer as first clinical target for exosome nanomedicine platform - [at noodls] - Consolidated income statement AIM: RENE 9 June 2016 ReNeuron Group plc ReNeuron Group plc (the "Company") (AIM: RENE), a UK-based global leader in the development of cell-based therapeutics, ...
06/08/16 06:35 PMReNeuron making good progress in clinical trial, says CFO - Proactive Investors USA & Canada
06/08/16 09:06 AMReNeuron clinical trial making progress - Proactive Investors UK
06/08/16 03:28 AMRetinitis pigmentosa Phase I/II clinical trial update and Notice of US Key Opinion Leader event - [at noodls] - ReNeuron Group plc (the 'Company') (AIM: RENE), a leading UK-based stem cell therapy development company, is pleased to provide an update on progress with the ongoing US Phase I/II dose escalation study ...
06/08/16 02:18 AMRetinitis pigmentosa update & Notice of KOL event - [at noodls] - AIM: RENE 8 June 2016 ReNeuron Group plc Retinitis pigmentosa Phase I/II clinical trial update and Notice of US Key Opinion Leader event ReNeuron Group plc (the 'Company') (AIM: RENE), a leading UK-based ...
05/31/16 08:19 AMReNeuron Group (LON:RENE) Analyst Target Changes - Share Trading News - ReNeuron Group (LON:RENE) Analyst Target ChangesShare Trading NewsReNeuron Group Plc (ReNeuron), based in the United Kingdom, is engaged in clinical-stage stem cell company. It is engaged in the research, development and commercial exploitation of stem cell technologies for therapeutic and non-therapeutic ...and more »
05/26/16 10:46 AMReneuron Group (LON:RENE) Morning Trade Volumes - Share Trading News - Share Trading NewsReneuron Group (LON:RENE) Morning Trade VolumesShare Trading NewsReNeuron Group Plc (ReNeuron), based in the United Kingdom, is engaged in clinical-stage stem cell company. It is engaged in the research, development and commercial exploitation of stem cell technologies for therapeutic and non-therapeutic ...and more »
02/26/16 12:55 PMAnalyst Coverage Updates - ReNeuron Group (LON:RENE) - Risers & Fallers - Analyst Coverage Updates - ReNeuron Group (LON:RENE)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of ReNeuron Group (LON:RENE). The latest broker reports which are currently outstanding on Wednesday 24th of February state 2 analysts have a rating of “strong buy”, ...and more »
02/26/16 12:55 PMCan ReNeuron Group Plc's Tomorrow Be Different? The Stock Increases Again - Business Standard Tribune - Can ReNeuron Group Plc's Tomorrow Be Different? The Stock Increases AgainBusiness Standard TribuneThe stock of ReNeuron Group Plc (LON:RENE) is a huge mover today! The stock increased 4.36% or GBX 0.12 on February 25, hitting GBX 2.87. ReNeuron Group Plc (LON:RENE) has declined 49.56% since July 27, 2015 and is downtrending.and more »
02/07/16 01:40 PMFTSE Miners: Don't look a gift horse.... - Proactive Investors UK - FTSE Miners: Don't look a gift horse....Proactive Investors UKResurgent FTSE Miners are waving the wooden spoon this morning, giving up ground as traders who dared bottom-pick over the last 3 weeks sensibly book some handsome and very welcome 10-40% profits following a helpful combination of USD weakness ...
02/03/16 01:38 PMStill selling the bounce? - Proactive Investors UK - Still selling the bounce?Proactive Investors UKEquity markets mixed this morning, with a little oil price strength stemming earlier declines. Markets could be moving on past a string of arguably expected Oil Major earnings reports, while we note the potential for this to be mere consolidation ahead ...
02/03/16 01:38 PMNorthland Capital Partners View on the City TechFinancials, Quarto Group, Access Intelligence - Proactive Investors UK - Northland Capital Partners View on the City TechFinancials, Quarto Group, Access IntelligenceProactive Investors UKTechFinancials has entered into JV agreement in the B2C business segment, with the aim of increasing the company's B2C market share. TechFinancials has struck an agreement with IBID Holdings Limited (the Partner), a Hong Kong registered company ...and more »
02/03/16 01:38 PMNWF chief confident of meeting profit targets in 2016 - Proactive Investors UK - NWF chief confident of meeting profit targets in 2016Proactive Investors UKNWF Group (LON:NWF) is a 140 year old company focused on food, feed and fuel and chief executive Richard Whiting spoke to Proactive about its latest results. The firm's latest results showed pre-tax profit rose 4% to £2.6mln on slightly lower revenue ...and more »
02/03/16 01:38 PMKEFI Minerals pleased funding is progressing according to plans - Proactive Investors UK - KEFI Minerals pleased funding is progressing according to plansProactive Investors UKHarry Adams, KEFI Minerals's chairman (LON:KEFI), says funding is moving according to plans after the group selected two African banks to provide US$60 mln of debt finance for the development of the Tulu Kapi gold project in Ethiopia. Adams says the ...and more »
02/01/16 01:36 PMBeaufort Securities Breakfast Alert: Ariana Resources, Ferrum Crescent, Keras and others - Proactive Investors UK - Beaufort Securities Breakfast Alert: Ariana Resources, Ferrum Crescent, Keras and othersProactive Investors UKAny group that can position itself to secure online revenues from the PRC's twin obsessions, namely Lottery and Poker, while monetizing an increasingly liberated market, will add considerable value. Beaufort considers the shares offer value up to 5p ...and more »
02/01/16 01:36 PMStrategic Minerals boss says project switch creates better return for shareholders - Proactive Investors UK - Strategic Minerals boss says project switch creates better return for shareholdersProactive Investors UKJohn Peters, executive chairman, said: “This opportunity came along in a sector that we believe has good medium and long-term prospects.” In a separate statement, the group said it had stopped activity on its Tatu coal project in New Zealand to ...and more »
02/01/16 01:36 PMReNeuron Gets Notice Of Grant For US Cell Cryopreservation P - London South East (registration) (blog) - BioPharma-Reporter.comReNeuron Gets Notice Of Grant For US Cell Cryopreservation PLondon South East (registration) (blog)"The US Notice of Allowance for our cell cryopreservation technology is an important further addition to ReNeuron's extensive patent estate. We have invested heavily in patents over the years, an investment that we believe will provide significant ...ReNeuron Receives Notice of Grant of Key US Patent on its Cell Cryopreservation Technologyag-IP-news Agencyall 5 news articles »
02/01/16 02:19 AMNotice of Grant of Key US Patent - [at noodls] - RNS Number : 5491N ReNeuron Group plc 01 February 2016 1 February 2016 AIM: RENE ReNeuron Group plc ReNeuron receives notice of grant of key US patent on its cell cryopreservation... This is an abstract ...
01/30/16 01:14 PMEverything's rosy, n'est ce pas? - Proactive Investors UK - Everything's rosy, n'est ce pas?Proactive Investors UKEquity markets still on the up, digesting the Fed's January policy update as a positive with the tough start to January and market volatility a potential negative for the US economy, likely keeping the US central bank from hiking rates quickly in 2016 ...and more »

Social

About ReNeuron Group Plc

ReNeuron Group Plc logoReNeuron Group Plc (ReNeuron), based in the United Kingdom, is engaged in clinical-stage stem cell company. It is engaged in the research, development and commercial exploitation of stem cell technologies for therapeutic and non-therapeutic applications. It develops cell-based therapies for disease conditions where the cells can be readily administered off-the-shelf to any eligible patient without the need for additional drug treatments. Its lead therapeutic candidate is its ReN001 stem cell therapy for the treatment of patients left disabled by the effects of a stroke. Its ReNcell products are used in academic and commercial sectors. Its ReN009 stem cell candidate is for the treatment of critical limb ischaemia, a side effect of diabetes. This treatment is in early-stage clinical development. Its ReN003 stem cell candidate is for the treatment of retina pigmentosa, a blindness-causing disease of the retina. This treatment is in late pre-clinical development.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: LON
  • Symbol: RENE
  • CUSIP:
Key Metrics:
  • Previous Close: $0.04
  • 50 Day Moving Average: $2.93
  • 200 Day Moving Average: $3.09
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $94.82M
  • Current Year EPS Consensus Estimate: $-0.73 EPS
  • Next Year EPS Consensus Estimate: $N/A EPS
Additional Links: